These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19695452)

  • 21. Analysis of implantable defibrillator longevity under clinical circumstances: implications for device selection.
    Knops P; Theuns DA; Res JC; Jordaens L
    Pacing Clin Electrophysiol; 2009 Oct; 32(10):1276-85. PubMed ID: 19796344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting ventricular arrhythmias in patients with ischemic heart disease: clinical application of the ECG-derived QRS-T angle.
    Borleffs CJ; Scherptong RW; Man SC; van Welsenes GH; Bax JJ; van Erven L; Swenne CA; Schalij MJ
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):548-54. PubMed ID: 19843923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design effects for highly clustered count data with varying length of follow-up--applying to the analysis of ICD shocks.
    Wang ZJ
    J Biopharm Stat; 2008; 18(1):31-43. PubMed ID: 18161540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of implantable cardioverter-defibrillators. Problems and progress in the design of randomized trials.
    Mower MM; Thomas AC; Nisam S; Graf AJ
    J Electrocardiol; 1993; 26 Suppl():42-50. PubMed ID: 8189144
    [No Abstract]   [Full Text] [Related]  

  • 25. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
    Goldberger JJ; Passman R
    J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable cardiac defibrillators.
    Donaldson RM
    N Engl J Med; 2002 Aug; 347(5):365-7; author reply 365-7. PubMed ID: 12151477
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical research designs and implantable defibrillator indications: spend in the beginning or pay at the end.
    Myerburg RJ; Castellanos A
    J Am Coll Cardiol; 2006 Jan; 47(1):108-11. PubMed ID: 16386672
    [No Abstract]   [Full Text] [Related]  

  • 28. Magnetic resonance imaging in patients with implantable cardiac devices.
    Sierra M; Machado C
    Rev Cardiovasc Med; 2008; 9(4):232-8. PubMed ID: 19122581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic hypothermia for acute myocardial infarction: past, present, and future.
    Parham W; Edelstein K; Unger B; Mooney M
    Crit Care Med; 2009 Jul; 37(7 Suppl):S234-7. PubMed ID: 19535952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
    de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
    Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usefulness of home monitoring in patients with implantable cardioverter-defibrillators].
    Pedrinazzi C; Inama G; Durin O; Munoz CV; De Simoni S; Fagandini F; Savazza R; Ablondi L
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):47S-51S. PubMed ID: 19195306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The psychological impact of implantable cardioverter-defibrillator recalls and the durable positive effects of counseling.
    Fisher JD; Koulogiannis KP; Lewallen L; Katz D; Kim SG; Ferrick KJ; Gross JN; Krumerman AK; Johnston DR; Mercaldi BC
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1012-6. PubMed ID: 19659621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of electromagnetic articulography in patients with pacemakers and implantable cardioverter-defibrillators.
    Joglar JA; Nguyen C; Garst DM; Katz WF
    J Speech Lang Hear Res; 2009 Aug; 52(4):1082-7. PubMed ID: 19641084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expenditure and value for money: the challenge of implantable cardioverter defibrillators.
    Boriani G; Biffi M; Martignani C; Diemberger I; Valzania C; Bertini M; Branzi A
    QJM; 2009 May; 102(5):349-56. PubMed ID: 19276209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
    de Oliveira JC; Martinelli M; Nishioka SA; Varejão T; Uipe D; Pedrosa AA; Costa R; D'Avila A; Danik SB
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):29-34. PubMed ID: 19808441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators.
    ; Vijgen J; Botto G; Camm J; Hoijer CJ; Jung W; Le Heuzey JY; Lubinski A; Norekvål TM; Santomauro M; Schalij M; Schmid JP; Vardas P
    Europace; 2009 Aug; 11(8):1097-107. PubMed ID: 19525498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.